Path ID: DB09229_MESH_D006973_1

db09229-mesh-d006973-1

Concepts

Identifier Name Type
MESH:C059427 aranidipine Drug
UniProt:Q13936 Voltage-dependent L-type calcium channel subunit alpha-1C Protein
UniProt:Q01668 Voltage-dependent L-type calcium channel subunit alpha-1D Protein
UniProt:O60840 Voltage-dependent L-type calcium channel subunit alpha-1F Protein
UniProt:Q13698 Voltage-dependent L-type calcium channel subunit alpha-1S Protein
GO:0006939 smooth muscle contraction BiologicalProcess
GO:0042310 vasoconstriction BiologicalProcess
HP:0032263 Increased blood pressure PhenotypicFeature
MESH:D006973 Hypertensive disorder Disease

Relationships

NOTE: predicates are annotated in Biolink Model (v1.3.0)

Subject Predicate Object
Aranidipine DECREASES ACTIVITY OF Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1C
Aranidipine DECREASES ACTIVITY OF Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1D
Aranidipine DECREASES ACTIVITY OF Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1F
Aranidipine DECREASES ACTIVITY OF Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1S
Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1C POSITIVELY REGULATES Smooth Muscle Contraction
Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1D POSITIVELY REGULATES Smooth Muscle Contraction
Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1F POSITIVELY REGULATES Smooth Muscle Contraction
Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1S POSITIVELY REGULATES Smooth Muscle Contraction
Smooth Muscle Contraction POSITIVELY CORRELATED WITH Vasoconstriction
Vasoconstriction POSITIVELY CORRELATED WITH Increased Blood Pressure
Increased Blood Pressure MANIFESTATION OF Hypertensive Disorder

Reference: